Greenfield L J, Cho K J, Proctor M, Bonn J, Bookstein J J, Castaneda-Zuniga W R, Cutler B, Ferris E J, Keller F, McCowan T
University of Michigan, Ann Arbor.
J Vasc Surg. 1991 Sep;14(3):253-7. doi: 10.1067/mva.1991.29913.
Initial efforts to modify the stainless steel Greenfield filter for percutaneous insertion led to development of a titanium Greenfield filter, which could be inserted by use of a 12F carrier. This device functioned well as a filter but had an unacceptable 30% rate of migration, tilting, and penetration. Therefore a titanium Greenfield filter with modified hooks was developed and has been tested in 186 patients at 10 institutions. Successful placement occurred in 181 (97%); placement of the remainder was precluded by unfavorable anatomy. A contraindication to anticoagulation was the most frequent indication for insertion (75%). All but two were inserted percutaneously, predominantly via the right femoral vein (70%). Initial incomplete opening was seen in four patients (2%), which was corrected by guide wire manipulation and asymmetry of the legs in 10 (5.4%). Insertion site hematoma occurred in one patient, and apical penetration of the cava during insertion occurred in a second patient. Both events were without sequelae. Follow-up examinations were performed at 30 days at which time 35 deaths had occurred. Recurrent embolism was suspected in six patients (3%) and two of three deaths were confirmed by autopsy. Filter movement greater than 9 mm was seen in 13 patients, (11%) and increase in base diameter greater than or equal to 5 mm was seen in 17 patients (14%). CT scanning showed evidence of caval penetration in only one patient (0.8%). Insertion site venous thrombosis was seen in 4/46 (8.7%) patients screened. The modified hook titanium Greenfield filter is inserted percutaneously or operatively through a sheath, eliminating concern for misplacement from premature discharge.(ABSTRACT TRUNCATED AT 250 WORDS)
为使格林菲尔德不锈钢滤器能经皮插入而进行的初步尝试,促使了钛制格林菲尔德滤器的研发,该滤器可通过12F输送器插入。此装置作为滤器功能良好,但有30%的移位、倾斜及穿透发生率,令人难以接受。因此,研发了一种带有改良钩的钛制格林菲尔德滤器,并在10家机构的186例患者中进行了测试。181例(97%)成功置入;其余患者因解剖结构不利而无法置入。抗凝禁忌是最常见的置入指征(75%)。除2例患者外,均经皮置入,主要通过右股静脉(70%)。4例患者(2%)出现初始不完全张开,通过导丝操作得以纠正;10例患者(5.4%)出现腿部不对称。1例患者发生插入部位血肿,另1例患者在插入时发生腔静脉顶端穿透。这两起事件均无后遗症。在30天时进行了随访检查,此时已有35例死亡。6例患者(3%)疑似复发性栓塞,3例死亡患者中有2例经尸检证实。13例患者(11%)滤器移位大于9 mm,17例患者(14%)滤器基部直径增加大于或等于5 mm。CT扫描仅在1例患者(0.8%)中显示有腔静脉穿透迹象。在接受筛查的46例患者中有4例(8.7%)出现插入部位静脉血栓形成。改良钩钛制格林菲尔德滤器可经皮或通过鞘管手术置入,消除了因过早出院导致误置的担忧。(摘要截选至250字)